Community Forum top_calendar.gif top_members.gif top_faq.gif top_search.gif top_home.gif    

Go Back   Community Forum > The Internet Medical Journal > News
User Name
FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Search this Thread Display Modes
Old July 8th, 2004, 11:28
sysadmin sysadmin is offline
Join Date: 2001
Posts: 1,085
New Research Gives a Scientific Basis for Frequency of PSA Testing

A Report from Large NCI Study Suggests PSA Testing Could Be Done at Longer Intervals for Men Who Choose to Test. Many men who choose to get a prostate specific antigen (PSA) test may not need to repeat the test as frequently as previously thought, according to data from the Prostate, Lung, Colorectal and Ovarian (PLCO) trial, sponsored by the National Cancer Institute (NCI). Results will be presented as abstract #4 in the general plenary session at the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Fla., on Monday, May 20, 2002.

"Men who choose PSA testing now have a scientific basis for choosing, with their physicians, how frequently they wish to be screened," said John Gohagan, Ph.D., NCI project officer for the trial.

The current analysis is based on results from almost 30,000 men enrolled in the PLCO trial who had annual PSA tests as part of the study. The researchers found that, in men with an initial PSA value between 0 to 1 ng/ml (nanogram of antigen per milliliter of fluid), 98.7 percent would continue to have PSA levels below 4 ng/ml through four additional years of PSA testing. Men whose last PSA was less than 1 ng/ml may want to consider screening less often than annually.

For men with initial PSA readings of 1 to 2 ng/ml, the investigators found that 98.8 percent would have a reading below 4 ng/ml in the subsequent year. For men with readings in the 2 to 4 ng/ml range, the chances that the PSA would rise to at least 4 ng/ml were higher. This was especially true for men in the 3 to 4 ng/ml range, because 24 percent of them would show elevated readings within a year and 83 percent would show elevated levels within four years, according to the PLCO data. Doctors often use the value of 4 ng/ml or greater as the trigger for further investigation, such as a prostate biopsy.

PSA testing is frequently used in an attempt to detect prostate cancer at an early stage. PSA is a protein produced by both normal and cancerous prostate cells and its levels can be elevated in men with prostate cancer or some non-cancerous conditions, such as benign prostatic hyperplasia or prostatitis. Many men over age 50 may have early, undiagnosed prostate cancer. Most of these cancers will remain harmless, but some will progress to clinically significant disease, according to autopsy studies done in recent years.

Since the late 1980s, PSA tests have been used by a large number of men. However, PSA testing has never been proven to reduce the risk of dying from prostate cancer. Elevated PSA readings many not always be indicative of an aggressive cancer and false positive results could lead to unnecessary invasive procedures and attendant risks; thus, PSA testing is not a universally recommended screening procedure.

"This is one of the first of many important pieces of research that will come from the PLCO study," said first author E. David Crawford, M.D., University of Colorado, Denver. "But we are not yet able to address the value of PSA testing itself, and those results will come in the future when more data from the trial have been assembled and analyzed."

The PLCO trial completed enrollment in September 2001. Screening of participants with annual PSA tests and other exams will continue until 2007, and follow-up will then continue in order to determine the benefits or harms of screening.
Reply With Quote

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Scientists Sue Federal Government for Blocking Medical Marijuana Research sysadmin News 0 July 22nd, 2004 16:08

All times are GMT -8. The time now is 09:08.

Powered by: vBulletin Version 3.0.3
Copyright ©2000 - 2018, Jelsoft Enterprises Ltd.

Be careful about reading health books. You may die of a misprint.  
- Mark Twain (1835 - 1910)

We are committed to your good health. That means that while we provide editorial medical information, we must insist that you work with your own doctor in regards to your personal health issues. All content on Medjournal.Com is strictly editorial. It constitutes medical opinion, NOT ADVICE. We do not endorse or recommend the content of or the sites that are linked FROM or TO Use common sense by consulting with your doctor before making any lifestyle changes or other medical decisions based on the content of these web pages. Medjournal.Com and the Internet Medical Journal shall not be held liable for any errors in content, advertising, or for any actions taken in reliance thereon.